日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Intraindividual epigenetic heterogeneity underlying phenotypic subtypes of advanced prostate cancer.

晚期前列腺癌表型亚型的个体内部表观遗传异质性

Mizuno Kei, Ku Sheng-Yu, Venkadakrishnan Varadha Balaji, Bakht Martin K, Sigouros Michael, Chan Joanna, Trigos Anna, Driskill Jordan H, Manohar Jyothi, King Abigail, Presser Adam G, Kim Min Jin, Tewari Alok K, Long Henry W, Quigley David, Choueiri Toni K, Balk Steven, Hill Sarah, Mosquera Juan Miguel, Einstein David, Sandhu Shahneen, Taplin Mary-Ellen, Beltran Himisha

Androgen deprivation-mediated activation of AKT is enhanced in prostate cancer with TMPRSS2:ERG fusion.

在具有 TMPRSS2:ERG 融合的前列腺癌中,雄激素剥夺介导的 AKT 激活增强。

Ma Fen, Chen Sen, Cecchi Luigi, Ersoy-Fazlioglu Betul, Russo Joshua W, Arai Seiji, Awad Seifeldin, Calagua Carla, Xie Fang, Poluben Larysa, Voznesensky Olga, Ku Anson T, Karzai Fatima, Cai Changmeng, Einstein David J, Ye Huihui, Yuan Xin, Toker Alex, Taplin Mary-Ellen, Sowalsky Adam G, Balk Steven P

Combined Fixed-duration Systemic Treatment and Metastasis-directed Radiotherapy for Oligometastatic Hormone-sensitive Prostate Cancer

寡转移性激素敏感性前列腺癌的固定疗程全身治疗联合转移灶定向放射治疗

Ravi, Praful; Zhong, Caiwei; Xie, Wanling; Kelly, Emma; Whelpley, Bridget; Kuczmarski, Katelyn; Beltran, Himisha; Kilbridge, Kerry L; King, Martin T; McGregor, Bradley A; Morgans, Alicia K; Pomerantz, Mark; Taplin, Mary-Ellen; Tewari, Alok K; Viswanathan, Srinivas R; Wei, Xiao X; Anh Huynh, Mai; Choudhury, Atish D

BCL2 drives castration resistance in castration-sensitive prostate cancer by orchestrating reciprocal crosstalk between oncogenic pathways.

BCL2 通过协调致癌通路之间的相互串扰,驱动去势敏感性前列腺癌产生去势抵抗

Hirani Rahim, Nandakumar Subhiksha, Zaman Nabila, Prabhakaraalva Prathiksha, King Sarah Ann, Kalidindi Teja Muralidhar, Ghale Romina, Rajanala Sai Harisha, Fidele Deborah C, De Stanchina Elisa, Mary Lee Gwo-Shu, Taplin Mary Ellen, Balk Steven P, Sowalsky Adam G, Morris Michael J, Kishore Pillarsetty Naga Vara, Stopsack Konrad H, Gopalan Anuradha, Mucci Lorelei A, Kyprianou Natasha, Tewari Ashutosh K, Danila Daniel, Kantoff Philip W, Chakraborty Goutam

Implementing evidence-based strategies for men with biochemically recurrent and advanced prostate cancer: Consensus recommendations from the US Prostate Cancer Conference 2024

针对生化复发和晚期前列腺癌患者实施循证策略:2024 年美国前列腺癌大会共识建议

Bryce, Alan H; Agarwal, Neeraj; Beltran, Himisha; Hussain, Maha H; Sartor, Oliver; Shore, Neal; Antonarakis, Emmanuel S; Armstrong, Andrew J; Calais, Jeremie; Carducci, Michael A; Dorff, Tanya Barauskas; Efstathiou, Jason A; Gleave, Martin; Gomella, Leonard G; Higano, Celestia; Hope, Thomas A; Iagaru, Andrei; Morgans, Alicia K; Morris, David S; Morris, Michael J; Petrylak, Daniel P; Reiter, Robert E; Rettig, Matthew B; Ryan, Charles J; Sellinger, Scott B; Spratt, Daniel E; Srinivas, Sandy; Tagawa, Scott T; Taplin, Mary-Ellen; Yu, Evan Y; Zhang, Tian; McKay, Rana R; Koo, Phillip J; Crawford, E David

Systemic treatment options for metastatic castration resistant prostate cancer: A living systematic review

转移性去势抵抗性前列腺癌的全身治疗方案:一项动态系统性综述

Naqvi, Syed Arsalan Ahmed; Anjum, Muhammad Umair; Bibi, Arifa; Khan, Muhammad Ali; Khakwani, Kaneez Zahra Rubab; He, Huan; Imran, Manal; Kazmi, Syeda Zainab; Raina, Ammad; Cobran, Ewan K; Bryan Rumble, R; Oliver, Thomas K; Agarwal, Neeraj; Zakharia, Yousef; Taplin, Mary-Ellen; Sartor, Oliver; Singh, Parminder; Orme, Jacob J; Childs, Daniel S; Parikh, Rahul A; Garje, Rohan; Murad, Mohammad Hassan; Bryce, Alan H; Riaz, Irbaz Bin

Immune Spatial Organization Predicts Metastasis Risk in Aggressive Localized Prostate Cancer

免疫空间组织可预测侵袭性局限性前列腺癌的转移风险

Yang, David D; Abdelnaser, Aya; Wala, Jeremiah; Haas, Alexander J; Barney, Alfred A; Saad, Eddy; Crowdis, Jett P; Ricker, Cora A; Park, Jihye; King, Martin T; Nguyen, Paul L; Choueiri, Toni K; Tewari, Alok K; Salari, Keyan; Taplin, Mary-Ellen; Wu, Chin-Lee; Van Allen, Eliezer M

PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19)

PRESTO:一项针对高危生化复发去势敏感性前列腺癌患者强化雄激素阻断治疗的 III 期开放标签研究 (AFT-19)

Aggarwal, Rahul; Heller, Glenn; Hillman, David W; Xiao, Han; Picus, Joel; Taplin, Mary-Ellen; Dorff, Tanya; Appleman, Leonard; Weckstein, Douglas; Patnaik, Akash; Bryce, Alan; Shevrin, Daniel; Mohler, James; Anderson, Daniel; Rao, Arpit; Tagawa, Scott; Tan, Alan; Halabi, Susan; Dooley, Katharine; O'Brien, Patrick; Chen, Ronald; Ryan, Charles J; Eggener, Scott E; Morris, Michael J

Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapy.

将 STING 激动剂靶向前列腺肿瘤中的血管周围巨噬细胞,可延缓对雄激素剥夺疗法的耐药性

Al-Janabi Haider, Moyes Katy, Allen Richard, Fisher Matthew, Crespo Mateus, Gurel Bora, Rescigno Pasquale, de Bono Johann, Nunns Harry, Bailey Christopher, Junker-Jensen Anna, Muthana Munitta, Phillips Wayne A, Pearson Helen B, Taplin Mary-Ellen, Brown Janet E, Lewis Claire E

Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer

BRCA2/SPOP 共突变预示转移性去势抵抗性前列腺癌对聚(ADP-核糖)聚合酶抑制剂具有极高的敏感性

Orme, Jacob J; Taza, Fadi; De Sarkar, Navonil; Tewari, Alok K; Arsalan Naqvi, Syed; Riaz, Irbaz B; Childs, Daniel S; Omar, Noha; Adra, Nabil; Ashkar, Ryan; Cheng, Heather H; Schweizer, Michael T; Sokolova, Alexandra O; Agarwal, Neeraj; Barata, Pedro; Sartor, Oliver; Bastos, Diogo; Smaletz, Oren; Berchuck, Jacob E; McClure, Heather; Taplin, Mary-Ellen; Aggarwal, Rahul; Sternberg, Cora N; Vlachostergios, Panagiotis J; Alva, Ajjai S; Mehra, Niven; Nelson, Peter S; Hwang, Justin; Dehm, Scott M; Shi, Qian; Fleischmann, Zoe; Sokol, Ethan S; Elliott, Andrew; Huang, Haojie; Bryce, Alan; Marshall, Catherine H; Antonarakis, Emmanuel S